Published in Clin Chim Acta on November 01, 1969
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities. J Clin Invest (1973) 0.82
Classification of hyperlipidaemias. Proc R Soc Med (1971) 0.75
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Some effects of oral contraceptives on serum-lipid and lipoprotein levels. Lancet (1966) 3.09
Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men. Soc Sci Med (1990) 2.63
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation (1993) 2.04
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation (1990) 1.89
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med (1993) 1.82
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther (2010) 1.76
Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med (1982) 1.67
Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions. Clin Chim Acta (1970) 1.53
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47
Urban runoff as a source of polycyclic aromatic hydrocarbons to coastal waters. Environ Sci Technol (1984) 1.46
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med (1996) 1.43
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest (1998) 1.42
Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron (1993) 1.42
Degradative effect of phenol on endotoxin and lipopolysaccharide preparations from Serratia marcescens. J Bacteriol (1974) 1.39
Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men. J Intern Med (1997) 1.38
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial. Circulation (1995) 1.38
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. MMW Fortschr Med (2000) 1.37
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
A simple specific method for precipitation of low density lipoproteins. J Lipid Res (1983) 1.33
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin Sci Mol Med (1973) 1.32
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res (2000) 1.25
Diagnosis and classification of abnormal lipoprotein patterns. Clin Chim Acta (1971) 1.23
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Apoliproproteins and lipoproteins. Atherosclerosis (1971) 1.17
Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med (2001) 1.17
Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res (1989) 1.17
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. Clin Chem (1976) 1.15
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation (1994) 1.14
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13
Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (2001) 1.13
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest (1994) 1.12
Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma. Biochemistry (1970) 1.12
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens 08. Biochemistry (1973) 1.11
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br J Cancer (2002) 1.08
Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol (2004) 1.07
Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06
The distribution and composition of serum lipoproteins in eighteen animals. Comp Biochem Physiol B (1971) 1.06
Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry (1972) 1.05
Lipoprotein particles from the Golgi apparatus of guinea-pig liver. Biochem J (1972) 1.05
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
The differential diagnosis of neonatal hepatitis and biliary atresia. J Pediatr Surg (1974) 1.04
Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS). Klin Wochenschr (1988) 1.04
Diet and Plasma Cholesterol in 99 Bank Men. Br Med J (1963) 1.03
Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res (1983) 1.03
Studies on the characterization of lipopolysaccharides from two strains of Serratia marcescens. Ann N Y Acad Sci (1966) 1.03
Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. Nephron (1991) 1.02
Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02
Studies of the composition and structure of serum lipoproteins. Separation and characterization of phospholipid-protein residues obtained by partial delipidization of very low density lipoproteins of human serum. Biochemistry (1966) 1.02
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects. Clin Cardiol (1999) 1.02
Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest (1974) 1.01
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01
Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett (1997) 1.01
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00
Composition and structure of the O-specific side chain of endotoxin from Serratia marcescens Bizio. Biochemistry (1973) 0.99
Circulating nucleosomes in serum. Ann N Y Acad Sci (2001) 0.99
Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta (1987) 0.98
Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta (1991) 0.98
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes (1998) 0.98
Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98
Some effects of diet on guinea pig serum lipoproteins. Biochim Biophys Acta (1972) 0.97
Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97
Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI. Hum Genet (1982) 0.96
Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res (1990) 0.96
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Effects of medium chain length triglyceride (MCT) on serum lipids and lipoproteins in familial hyperchylomicronemia (dietary fat-induced lipemia) and dietary carbohydrate-accentuated lipemia. J Lab Clin Med (1965) 0.95
Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim Biophys Acta (1996) 0.94
Apoptosis in serum of patients with solid tumours. Anticancer Res (1999) 0.94
Fasting serum triglyceride, cholesterol, and lipoprotein levels during oral-contraceptive therapy. Lancet (1969) 0.93
Epidemiological evidence for work load as a risk factor for osteoarthritis of the hip: a systematic review. PLoS One (2012) 0.93
The activity of different fractions of homologous thyroid extract in the production of allergic thyroiditis in the rat. Immunology (1965) 0.93
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy. J Acquir Immune Defic Syndr (2001) 0.93
Distribution and characterization of the serum lipoproteins and their apoproteins in the rainbow trout (Salmo gairdnerii). Biochemistry (1978) 0.93
Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL). Clin Neuropathol (1982) 0.93
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol (1998) 0.92
David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem (1981) 0.92
Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun (1998) 0.92
Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids. Am J Physiol (1996) 0.92
Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochim Biophys Acta (1972) 0.92
Computed tomography in late-onset metachromatic leucodystrophy. Neuroradiology (1984) 0.92